Cash Flow from Operating Activities: A company's cash flows from operations.
Mainz Biomed NV (QUCY) had Cash Flow from Operating Activities of $-10.98M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.54M |
|
$-16.21M |
|
$0.15M |
|
$0.39M |
|
$16.68M |
|
$-16.14M |
|
$-0.07M |
|
$-16.21M |
|
$-16.05M |
|
$-16.21M |
|
$-16.21M |
|
$-16.21M |
|
$-16.05M |
|
$-16.14M |
|
$-15.52M |
|
6.00M |
|
6.00M |
|
$-2.70 |
|
$-2.70 |
|
| Balance Sheet Financials | |
$1.84M |
|
$1.09M |
|
$3.49M |
|
$5.33M |
|
$3.69M |
|
$0.99M |
|
$0.99M |
|
$4.69M |
|
$0.64M |
|
$-0.47M |
|
$0.64M |
|
9.78M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-10.98M |
$-1.03M |
|
$6.76M |
|
$6.24M |
|
$0.89M |
|
$-5.35M |
|
$2.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.50 |
|
-- |
|
-- |
|
0.61 |
|
4.01 |
|
72.58% |
|
-3004.97% |
|
-3004.97% |
|
-2890.33% |
|
-3018.31% |
|
-3018.31% |
|
$-10.96M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.68 |
|
6.85 |
|
53.27 |
|
-2526.61% |
|
3435.76% |
|
-304.29% |
|
-992.04% |
|
$0.07 |
|
$-1.83 |
|
$-1.83 |
|